We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.90
Bid: 151.50
Ask: 152.00
Change: 0.90 (0.60%)
Spread: 0.50 (0.33%)
Open: 148.80
High: 152.40
Low: 147.60
Prev. Close: 151.00
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement re: Rights Issue

13 Mar 2020 16:36

RNS Number : 1617G
Aston Martin Lagonda Global Hld PLC
13 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, CHINA OR SOUTH AFRICA.

NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF ANY NIL PAID RIGHTS, FULLY PAID RIGHTS OR NEW SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS TAKEN TOGETHER WITH ANY SUPPLEMENTARY PROSPECTUS. COPIES OF THE PROSPECTUS AND THE SUPPLEMENTARY PROSPECTUS, EXPECTED TO BE PUBLISHED LATER TODAY, FOLLOWING PUBLICATION OF THE SUPPLEMENTARY PROSPECTUS, BE AVAILABLE FROM THE REGISTERED OFFICE OF THE COMPANY AND ON ITS WEBSITE AT WWW.ASTONMARTINLAGONDA.COM.

13 March 2020

Aston Martin Lagonda Global Holdings plc

("Aston Martin Lagonda", the "Company" or the "Group")

Update to the announcement of 27 February Proposed capital raise increased to £536 million (the "Capital Raise")

In light of recent extraordinary equity market volatility related to concerns over Covid-19, the Company has renegotiated certain terms relating to the proposed investment by the consortium led by Lawrence Stroll (the "Consortium") and the subsequent rights issue. These new terms will provide further safeguards to the Company in the short and long term.

The spread of Covid-19 is creating significant challenges for many companies. Aston Martin Lagonda continues to manage proactively across its supply chain and business more broadly.

- The primary concern of the Company remains the health and safety of colleagues and their families, business partners and the local communities and the Company continues to provide all the support possible. Public health measures advised by governments are being followed in support of their efforts to contain the spread of the virus.

- Despite disruption to supply of some tier 2 components from China, there has been no impact on production to date. Supply is secured until at least early April and the Company continues to monitor its suppliers and inventory as it seeks to extend this profile to mitigate future potential disruption.

- Covid-19 has negatively impacted economic conditions globally, has impacted customer demand in China and APAC and has potential to do the same in other markets increasing uncertainties and risks to the financial performance of the Company in 2020.

o The Company responded to the cancellation of the Geneva Motor Show with a social media led launch of the Vantage Roadster and the V12 Speedster.

o Concerns about the virus have also led to the cancellation or postponement of events such as some F1TM races and the launch of the new James Bond film from April to November.

The first two months of the year were planned conservatively with wholesales expected to be lower year-on-year as the Company focuses on reducing dealer inventories to a luxury norm. Specifically, no wholesales were planned in China for the period. In terms of trading year-to-date:

- Retail sales (dealer sales to customers) were slightly ahead of plan and wholesales (sales to dealers) were in-line with the Company's expectations and reset objectives;

- Dealer inventories have consequently reduced by c.300 units;

- The DBX order book has continued to build and the Company is now taking retail orders into 2021.

The proposed Capital Raise, which remains subject to shareholder approval (as outlined below), is amended as follows:

- Total Capital Raise is increased by £36 million to £536 million, as an appropriate measure reflecting increased uncertainties since the announcement of 27 February. It is proposed that:

o The Consortium will take a position of approximately 25% of the post-placing issued share capital of the Company for £2.25 per share and follow its rights in full.

o The subsequent proposed committed and underwritten rights issue (the "Rights Issue") will raise c.£365 million further details of which are announced below.

- Short-term working capital support from Yew Tree, a vehicle controlled by Lawrence Stroll, is increased to £75.5 million to support resilience and immediate liquidity needs given the revised timetable for the Capital Raise.

Full revised terms of the Capital Raise will be disclosed in a supplementary prospectus, expected to be published by the Company later today (the "Supplementary Prospectus"). The Supplementary Prospectus will also include a notice of a new general meeting that will be convened to seek the necessary shareholder approvals for the revised terms of the Capital Raise (the "New General Meeting"). Although the timetable is conditional on FCA approval of the Supplementary Prospectus, the New General Meeting is currently expected to be on 30 March. Full details on timing will be provided in the Supplementary Prospectus.

Following renegotiation of the terms agreed with the Consortium and the revision of the terms of the Capital Raise, the resolutions to be proposed at the general meeting previously convened for 10.00 a.m. on 16 March 2020 (the "16 March General Meeting") are now redundant. Accordingly, the Board intends to take the necessary steps to adjourn indefinitely the 16 March General Meeting. Shareholders will therefore not need to attend the 16 March General Meeting, but should instead attend, or submit their vote by proxy (in accordance with the instructions for doing so to be set out in the Supplementary Prospectus) for, the New General Meeting.

The Board believes the measures agreed with Mr Stroll and other large shareholders represent responsible action against a range of possible scenarios given the recent volatility.

 

Commenting on this announcement Dr Andy Palmer, Aston Martin Lagonda President and Group CEO said:

"We are actively managing the potential impacts of Covid-19 on a daily basis, most particularly in our tier 2 supply chain, with no disruption to production to date and are mindful of the ongoing uncertainties and risks to the business. The first two months of the year were planned to be our smallest in wholesale unit terms, as we start to rebalance supply and demand; a key component of our plan to turn around performance and restore our price positioning. Trading has generally been in line with these conservative expectations, with retail performance slightly better than planned.

In light of the increased uncertainty presented by Covid-19 we are taking actions to safeguard the Company through this extremely volatile period.

The third production trial of DBX at St Athan, where we test the facility and our suppliers at run rate and to final customer quality standards, is proceeding as planned. We unveiled the Vantage Roadster, a key component of the Vantage relaunch with a digital event last week and development of Aston Martin Valkyrie continues apace and to plan."

 

Lawrence Stroll said:

"There has been a significant change in the global market environment in which Aston Martin Lagonda operates. What has not changed is our commitment to provide the Company with the necessary funding it needs to manage through this period, to reset the business and to deliver on its long-term potential. Following recent moves in the share price and discussions with the Board, I and my consortium of investors, have agreed that we will now acquire 25% of the company and take up our rights in full in return for a long-term capital Investment of £262 million. In addition, we have agreed to advance a further £20 million in short term funding to support the company, bringing this total amount to £75.5 million. Whilst the immediate outlook looks increasingly challenging, I remain fully committed to the future of Aston Martin Lagonda and look forward to implementing our plans once the fundraising is complete."

 

Details of the Capital Raise

- Strategic equity investment of £171 million (the "Placing") by the Consortium

o Through the issue of 76 million new ordinary shares in the capital of the Company at a price of £2.25 per share to the Consortium, representing approximately 25.0% of the post-Placing issued share capital of the Company;

o The provision in the placing agreement that allowed the Consortium to terminate the agreement in the event of a material adverse change in the condition of the Company or the market has been removed from the restated placing agreement to provide further certainty to the Capital Raise.

- Fully underwritten Rights Issue of £365 million supported by Prestige/Strategic European Investment Group (SEIG) and Adeem/Primewagon (the "Major Shareholders")

o Prestige/Strategic European Investment Group (SEIG) and Adeem/Primewagon who together own c.57.2% of the issued share capital of the Company as at the date of this announcement and who are expected to own c.42.9% following the proposed Placing have irrevocably undertaken to vote in favour of the Placing and the Rights Issue;

o Prestige/SEIG have irrevocably undertaken to take up their rights in the Rights Issue in full as has the Consortium;

o Adeem/Primewagon have irrevocably undertaken to take up 26.5% of their rights in the Rights Issue;

o Mercedes-Benz AG and Torreal Sociedad de Capital Riesgo, S.A. (which was previously part of the Prestige/SEIG shareholder group) which own 4.2% and 3.1% respectively of the issued share capital of the Company as at 9 March 2020 (being the latest practicable date prior to the publication of this announcement) have both irrevocably undertaken to (i) vote in favour of the Placing and the Rights Issue; and (ii) to take up their rights in full;

o The Company has therefore received irrevocable undertakings from shareholders representing 64.5% of the issued share capital of the Company as at the date of this announcement to vote in favour of the Placing and the Rights Issue; those shareholders and the Consortium will hold 73.4% of the post-placing share capital of the Company;

o In aggregate, the Company has received commitments to take up rights representing 58.2% of the entitlements in respect of the Rights Issue.

 

Details of the Rights Issue

- The Company today announces the details of a four for one fully committed and underwritten Rights Issue of 1,216 million New Shares to raise gross proceeds of approximately £365 million.

- The issue price of 30 pence per New Share represents:

o a discount of 86.0% to the Closing Price on 12 March 2020 (being the last business day prior to the date of this announcement); and

o a 55.1% discount to the theoretical ex-rights price of 67 pence per New Share calculated by reference to the Closing Price on the same basis.

- The Rights Issue, which is subject to shareholder approval, is underwritten by Deutsche Bank, J.P. Morgan Cazenove and Morgan Stanley.

 

Further details of the Consortium investment

- As part of the investment from the Consortium:

o In addition to the £55.5 million of short-term working capital support provided in February to support the liquidity of the Company, Yew Tree, a vehicle controlled by Mr. Stroll, has agreed to provide up to a further £20 million during the course of the next few days. Upon settlement of the Placing, it is intended that this £75.5 million will be set off against the proceeds of the Placing, and the Company would still no longer plan to draw the $100 million of Delayed Draw Notes.

Board changes

- As a result of the amended timetable for the Capital Raise, Lawrence Stroll will now succeed Penny Hughes as Chair on completion of the Rights Issue which is now expected to be 20 April.

- The Board has agreed that the board appointment rights contained in the relationship agreements entered into by the Consortium - as well as for Prestige/SEIG and Adeem/Primewagon - be amended to reduce the threshold at which each shareholder group will have the right to appoint two directors to the Board. This will be for so long as a shareholder group's holding of voting rights in the Company is equal to or exceeds the lower of 10% and the percentage of voting rights held by Adeem/Primewagon following each of the Placing and the Rights Issue (as applicable), provided such holding is above 7%.

Supplementary Prospectus

- The Supplementary Prospectus containing full details of the Capital Raise is expected to be published and made available on the Company's website (https://www.astonmartinlagonda.com/) later today and should be read in conjunction with the original prospectus issued on 27 February 2020 (the "Original Prospectus").

- The Supplementary Prospectus will be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/nsm following publication.

This announcement should be read in conjunction with the Original Prospectus and the Supplementary Prospectus.

Indicative updated abridged timetable

Although the timetable is conditional on FCA approval of the Supplementary Prospectus, the Company expects the updated abridged timetable to be as follows. Full details on timing will be provided in the Supplementary Prospectus.

Publication and posting of the Supplementary Prospectus (including the Notice of General Meeting) and the Form of Proxy

13 March 2020

Latest time and date for receipt of 30 March General Meeting Voting Instruction Forms (for shareholders holding through the Equiniti Corporate Sponsored Nominee)

10.00 a.m. on 25 March 2020

Latest time and date for receipt of 30 March General Meeting Forms of Proxy

10.00 a.m. on 26 March 2020

30 March General Meeting

10.00 a.m. on 30 March 2020

Issue of the Placing Shares

30 March 2020

Record Date for entitlements under the Rights Issue

Close of business on 30 March 2020

Listing and Admission of the Placing Shares

8.00 a.m. on 31 March 2020

Despatch of Provisional Allotment Letters

31 March 2020

Dealings in New Shares, nil paid, commence on the London Stock Exchange

8.00 a.m. on 1 April 2020

Shares marked ex-Rights

8.00 a.m. on 1 April 2020

Latest time and date for acceptance and payment in full and registration of renounced Provisional Allotment Letters

11.00 a.m. on 17 April 2020

Dealings in the New Shares to commence on the London Stock Exchange fully paid

8.00 a.m. on 20 April 2020

 

 

 

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is being released on behalf of Aston Martin Lagonda Global Holdings plc by Catherine Sukmonowski, Company Secretary.

 

The financial information contained herein is unaudited and certain financial data within this announcement have been rounded.

 

 

Enquiries

Investors and Analysts

Charlotte Cowley Director of Investor Relations +44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Toby Bates Senior Adviser, Financial Communications +44 (0)7584 773837

toby.bates1@astonmartin.com

Grace Barnie Corporate Communication Manager +44 (0)7880 903490

grace.barnie@astonmartin.com

Brunswick

Dan Roberts, Diana Vaughton +44 (0)20 7404 5959

astonmartin@brunswickgroup.com

 

 

Morgan Stanley (Sole Financial Adviser, Sponsor & Joint Global Co-ordinator & Bookrunner)Andrew Foster +44 (0)20 7425 8000

Mark Rawlinson

Anthony Zammit

Martin Thorneycroft

 

Deutsche Bank (Joint Corporate Broker, Joint Global Co-ordinator & Bookrunner)

Matt Hall +44 (0)20 7545 8000

Saadi Soudavar

Reinhard Kuehn

Mark Hankinson

 

J.P. Morgan Cazenove (Joint Corporate Broker, Joint Global Co-ordinator & Bookrunner)

Robert Constant   +44 (0)20 7742 4000

Virginia Khoo

Luca Santini

Alex Watkins

 

 

 

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its accuracy or completeness. The information in this announcement is subject to change.

This announcement is not a prospectus but an advertisement. Neither this announcement nor anything contained in it shall form the basis of, or be relied upon in conjunction with, any offer or commitment whatsoever in any jurisdiction. Investors should not acquire any Nil Paid Rights, Fully Paid Rights or New Shares referred to in this announcement except on the basis of the information contained in the Original Prospectus and the Supplementary Prospectus to be published by the Company in connection with the Rights Issue.

A copy of the Original Prospectus is, and a copy of the Supplementary Prospectus will following publication be, available from the registered office of the Company and on its website at www.astonmartinlagonda.com. Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement. The Original Prospectus and Supplementary Prospectus will provide further details of the New Shares, the Nil Paid Rights and the Fully Paid Rights being offered pursuant to the Rights Issue.

This announcement does not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States. The Nil Paid Rights, the Fully Paid Rights, the New Shares and the Provisional Allotment Letters have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the Nil Paid Rights, the Fully Paid Rights or the New Shares in the United States. Subject to certain limited exceptions, Provisional Allotment Letters have not been, and will not be, sent to, and Nil Paid Rights have not been and will not be credited to the CREST account of, any Qualifying Shareholder with a registered address in or that is located in the United States. None of the New Shares, the Nil Paid Rights, the Fully Paid Rights, Provisional Allotment Letters or the Form of Proxy, this announcement or any other document connected with the Rights Issue has been or will be approved or disapproved by the United States Securities and Exchange Commission or by the securities commissions of any state or other jurisdiction of the United States or any other regulatory authority, and none of the foregoing authorities or any securities commission has passed upon or endorsed the merits of the offering of the New Shares, the Nil Paid Rights, the Fully Paid Rights, Provisional Allotment Letters, the Form of Proxy or the accuracy or adequacy of this announcement or any other document connected with the Rights Issue. Any representation to the contrary is a criminal offence in the United States.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, Nil Paid Rights, Fully Paid Rights or New Shares or to take up any entitlements to Nil Paid Rights in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, Nil Paid Rights, Fully Paid Rights or New Shares or to take up any entitlements to Nil Paid Rights will be made in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States or Australia, Canada, Japan, the People's Republic of China or the Republic of South Africa, and should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Original Prospectus, the Supplementary Prospectus (once published) and the Provisional Allotment Letters (once printed) should not be distributed, forwarded to or transmitted in or into the United States or any other Excluded Territory.

Recipients of this announcement, the Original Prospectus and/or the Supplementary Prospectus should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement, the Original Prospectus and/or if and when published the Supplementary Prospectus. This announcement does not constitute a recommendation concerning any investor's options with respect to the Rights Issue. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each Shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

Notice to all investors

Morgan Stanley & Co. International plc ("Morgan Stanley") is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and Financial Conduct Authority. Morgan Stanley is acting for Aston Martin Lagonda Global Holdings plc in relation to the Capital Raise, will not regard any other person as a client in relation to the Placing and Rights Issue and will not be responsible to anyone other than Aston Martin Lagonda Global Holdings plc for providing the protections afforded to clients of Morgan Stanley nor for providing advice to any such other person.

Deutsche Bank AG is authorised under German Banking Law (competent authority: European Central Bank) and, in the United Kingdom, by the Prudential Regulation Authority (the "PRA"). It is subject to supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the PRA and the Financial Conduct Authority (the "FCA"). Details about the extent of its authorisation and regulation by the PRA, and regulation by the FCA, are available on request. Deutsche Bank AG, acting through its London branch ("Deutsche Bank"), is acting for Aston Martin Lagonda and no other person in connection with the Capital Raise. Neither Deutsche Bank, nor any of its subsidiaries, branches or affiliates will be responsible to any person other than Aston Martin Lagonda for providing any of the protections afforded to clients of Deutsche Bank nor for providing advice in relation to the Capital Raise or any matters referred to in this Announcement.

J.P. Morgan Securities plc (which conducts its UK investment banking business as "J.P. Morgan Cazenove") is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and Financial Conduct Authority. J.P. Morgan Cazenove is acting for Aston Martin Lagonda Global Holdings plc and no other person in connection with the Capital Raise and will not be responsible to anyone other than Aston Martin Lagonda Global Holdings plc for providing the protections afforded to clients of J.P. Morgan Cazenove nor for providing advice to any person in relation to the Capital Raise or any matters referred to in this announcement.

Barclays Bank PLC, acting through its investment bank ("Barclays"), which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for SHL Capital (UK) Limited (an affiliate of Yew Tree) and no one else in connection with the transaction referred to herein and will not be responsible to anyone other than SHL Capital (UK) Limited for providing the protections afforded to clients of Barclays nor for providing advice in relation to the Capital Raise or any other matter referred to in this announcement.

None of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays, nor any of their respective subsidiaries, branches or affiliates, nor any of their respective directors, officers or employees owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays in connection with the Capital Raise, this Announcement, any statement contained herein, or otherwise.

Cautionary statement regarding forward-looking statements

This announcement contains forward-looking statements, including with respect to financial information, that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "will", "may", "should", "would", "could", "is confident", or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this announcement and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and the Company's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. No representation or warranty is made that any forward-looking statement will come to pass.

You are advised to read the Original Prospectus and, when published, the Supplemental Prospectus, in their entirety, and, in particular, the sections of the Original Prospectus and Supplemental Prospectus headed "Risk Factors", for a further discussion of the factors that could affect the Group's future performance and the industry in which it operates. In light of these risks, uncertainties and assumptions, the events described in the forward looking statements, including statements regarding prospective financial information, in this announcement may not occur. These statements are not fact and should not be relied upon as being necessarily indicative of future results, and readers of this announcement are cautioned not to place undue reliance on the forward-looking statements, including those regarding prospective financial information.

No statement in this announcement is intended as a profit forecast, and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published operating profit or set a minimum level of operating profit.

Neither the Company nor any of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays are under any obligation to update or revise publicly any forward-looking statement contained within this announcement, whether as a result of new information, future events or otherwise, other than in accordance with their legal or regulatory obligations (including, for the avoidance of doubt, the Prospectus Regulation Rules, the Listing Rules and Disclosure Guidance and Transparency Rules).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ARIEAKDDFDDEEFA
Date   Source Headline
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights
10th Jul 20238:56 amRNSAdditional Listing and Total Voting Rights
6th Jul 20238:16 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSAdmission of New Shares for Warrant exercise
27th Jun 20237:00 amRNSCapital Markets Day 2023
26th Jun 20237:00 amRNSAston Martin Lagonda and Lucid Group, Inc.
26th Jun 20237:00 amRNSAston Martin Lagonda and Mercedes-Benz AG
31st May 20239:18 amRNSHolding(s) in Company
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.